4.8 Review

MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer

Journal

FRONTIERS IN IMMUNOLOGY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2018.00546

Keywords

microRNAs; nuclear factor kappa B; cancer; molecular therapy; nuclear factor kappa B-associated resistance

Categories

Funding

  1. National Natural Science Foundation of China [31472185, U1703104, 31201900]
  2. National Key Basic Research Program (973 program) of China [2015CB150300]
  3. State Public-interest Institution Basal Research Fund [1610312016017]

Ask authors/readers for more resources

Nuclear factor kappa B (NF-kappa B) is a pluripotent and crucial dimer transcription factor that orchestrates various physiological and pathological processes, especially cell proliferation, inflammation, and cancer development and progression. NF-kappa B expression is transient and tightly regulated in normal cells, but it is activated in cancer cells. Recently, numerous studies have demonstrated microRNAs (miRNAs) play a vital role in the NF-kappa B signaling pathway and NF-kappa B-associated immune responses, radioresistance and drug resistance of cancer, some acting as inhibitors and the others as activators. Although it is still in infancy, targeting NF-kappa B or the NF-kappa B signaling pathway by miRNAs is becoming a promising strategy of cancer treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available